CH642459A5 - Procede de preparation d'un support d'epreuve radioimmunologique en phase solide et son application. - Google Patents
Procede de preparation d'un support d'epreuve radioimmunologique en phase solide et son application. Download PDFInfo
- Publication number
- CH642459A5 CH642459A5 CH293879A CH293879A CH642459A5 CH 642459 A5 CH642459 A5 CH 642459A5 CH 293879 A CH293879 A CH 293879A CH 293879 A CH293879 A CH 293879A CH 642459 A5 CH642459 A5 CH 642459A5
- Authority
- CH
- Switzerland
- Prior art keywords
- columns
- gel
- solid phase
- antigen
- antibody
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 25
- 239000007790 solid phase Substances 0.000 title claims description 22
- 238000002360 preparation method Methods 0.000 title claims description 12
- 238000012360 testing method Methods 0.000 title description 9
- 238000003127 radioimmunoassay Methods 0.000 claims description 18
- 239000000427 antigen Substances 0.000 claims description 17
- 102000036639 antigens Human genes 0.000 claims description 17
- 108091007433 antigens Proteins 0.000 claims description 17
- 102000004169 proteins and genes Human genes 0.000 claims description 12
- 108090000623 proteins and genes Proteins 0.000 claims description 12
- 239000003153 chemical reaction reagent Substances 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 5
- 238000012546 transfer Methods 0.000 claims description 5
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 4
- 230000008961 swelling Effects 0.000 claims description 3
- 235000019739 Dicalciumphosphate Nutrition 0.000 claims description 2
- 239000001506 calcium phosphate Substances 0.000 claims description 2
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 claims description 2
- 229940038472 dicalcium phosphate Drugs 0.000 claims description 2
- 229910000390 dicalcium phosphate Inorganic materials 0.000 claims description 2
- 239000007791 liquid phase Substances 0.000 claims description 2
- 235000019359 magnesium stearate Nutrition 0.000 claims description 2
- 230000001131 transforming effect Effects 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims 1
- 239000000499 gel Substances 0.000 description 29
- 239000000872 buffer Substances 0.000 description 20
- 239000007788 liquid Substances 0.000 description 13
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
- 239000000203 mixture Substances 0.000 description 11
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 238000011534 incubation Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 239000012153 distilled water Substances 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 230000027455 binding Effects 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 229920002684 Sepharose Polymers 0.000 description 4
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000001179 sorption measurement Methods 0.000 description 4
- 229920002307 Dextran Polymers 0.000 description 3
- 229920005654 Sephadex Polymers 0.000 description 3
- 239000012507 Sephadex™ Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 102000007562 Serum Albumin Human genes 0.000 description 2
- 108010071390 Serum Albumin Proteins 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 102000011923 Thyrotropin Human genes 0.000 description 2
- 108010061174 Thyrotropin Proteins 0.000 description 2
- 239000003463 adsorbent Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 238000005056 compaction Methods 0.000 description 2
- 238000005336 cracking Methods 0.000 description 2
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 238000004452 microanalysis Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000012088 reference solution Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000297566 Saula Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000007374 clinical diagnostic method Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012631 diagnostic technique Methods 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005495 thyroid hormone Substances 0.000 description 1
- 229940036555 thyroid hormone Drugs 0.000 description 1
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
- G01N33/538—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by sorbent column, particles or resin strip, i.e. sorbent materials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/968—High energy substrates, e.g. fluorescent, chemiluminescent, radioactive
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/891,650 US4170454A (en) | 1978-03-30 | 1978-03-30 | Process for the preparation of a solid-phase radioimmunoassay support and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH642459A5 true CH642459A5 (fr) | 1984-04-13 |
Family
ID=25398594
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH293879A CH642459A5 (fr) | 1978-03-30 | 1979-03-29 | Procede de preparation d'un support d'epreuve radioimmunologique en phase solide et son application. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US4170454A (enExample) |
| JP (1) | JPS5925185B2 (enExample) |
| AU (1) | AU528893B2 (enExample) |
| CA (1) | CA1118346A (enExample) |
| CH (1) | CH642459A5 (enExample) |
| DE (1) | DE2912239C2 (enExample) |
| FR (1) | FR2421381A1 (enExample) |
| GB (1) | GB2017909B (enExample) |
| SE (1) | SE437731B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4244694A (en) * | 1978-03-31 | 1981-01-13 | Union Carbide Corporation | Reactor/separator device for use in automated solid phase immunoassay |
| US4259207A (en) * | 1979-09-19 | 1981-03-31 | American Hospital Supply Corporation | Suspending medium for immunologic reactions |
| US4623629A (en) | 1983-10-31 | 1986-11-18 | Daniel Kerschensteiner | Solid-phase immunoassay support and method of use thereof |
| US5229268A (en) * | 1986-07-14 | 1993-07-20 | Abbott Laboratories | Method for diagnostic immunoassay by solid phase separation |
| NO892244L (no) * | 1988-06-06 | 1989-12-07 | Photest Diagnostics Inc | Fremgangsmaate til immundiagnostisk bestemmelse. |
| US7108800B2 (en) | 2004-05-14 | 2006-09-19 | Nalco Company | Method for preventing the agglomeration or generation of dust from a particulate material comprising coal |
| JP6023943B2 (ja) | 2009-12-22 | 2016-11-09 | ジーイー・ヘルスケア・バイオプロセス・アールアンドディ・アクチボラグ | クロマトグラフィーカラムを乾式充填する方法 |
| WO2025125266A1 (en) * | 2023-12-11 | 2025-06-19 | Cube Biotech Gmbh | Tablets containing fuctionalized agarose particles, method for producing them and use of the tablets |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA990416A (en) * | 1972-04-19 | 1976-06-01 | Sieuwko J. Mantel | Device suitable for use in radioimmunoassay and method of determining the content of a specific hormone in a serum sample |
| SE343949B (enExample) * | 1966-06-02 | 1972-03-20 | Pharmacia Ab | |
| FR1527279A (fr) * | 1966-06-02 | 1968-05-31 | Pharmacia Ab | Procédé et réactif de dosage des protéines et des polypeptides, par exemple des hormones, dans un échantillon aqueux |
| US3996162A (en) * | 1970-02-27 | 1976-12-07 | Nuclear Medical Laboratories, Inc. | Analytical sorbent and method of use |
| AU2919171A (en) * | 1970-05-27 | 1972-11-30 | Pharmacia Ab | A method for carrying out tests, a reagent andan additive for carrying out the method |
| US3659104A (en) * | 1970-06-29 | 1972-04-25 | Univ Jerusalem The | Method of measuring serum thyroxine |
| IL42105A (en) * | 1973-04-25 | 1976-08-31 | Yissum Res Dev Co | Process for determination of triiodothyronine |
| US3925017A (en) * | 1973-05-01 | 1975-12-09 | Wisconsin Alumni Res Found | Preparation of dry, porous gel particles having high water regain for liquid sampling |
| US4070348A (en) * | 1973-07-25 | 1978-01-24 | Rohm Gmbh | Water-swellable, bead copolymer |
| US4039652A (en) * | 1973-10-11 | 1977-08-02 | Miles Laboratories, Inc. | Column method of immunoassay employing an immobilized binding partner |
| US3980764A (en) * | 1973-11-05 | 1976-09-14 | Curtis Nuclear Corporation | Polymeric competitive protein binding adsorbents for radioassey |
| US3953172A (en) * | 1974-05-10 | 1976-04-27 | Union Carbide Corporation | Method and apparatus for assaying liquid materials |
| US3947352A (en) * | 1974-05-31 | 1976-03-30 | Pedro Cuatrecasas | Polysaccharide matrices for use as adsorbents in affinity chromatography techniques |
| US4061466A (en) * | 1974-10-16 | 1977-12-06 | Ingvar Gosta Holger Sjoholm | Biologically active composition and the use thereof |
| US4018883A (en) * | 1975-03-10 | 1977-04-19 | Nichols Institute For Endocrinology | Thyroxine (T4) radioimmunoassay |
| JPS5267395A (en) * | 1975-12-01 | 1977-06-03 | Japan Exlan Co Ltd | Opening prcess for high density filling column in liquid chromatography |
-
1978
- 1978-03-30 US US05/891,650 patent/US4170454A/en not_active Expired - Lifetime
-
1979
- 1979-03-15 CA CA000323523A patent/CA1118346A/en not_active Expired
- 1979-03-28 DE DE2912239A patent/DE2912239C2/de not_active Expired
- 1979-03-29 JP JP54036350A patent/JPS5925185B2/ja not_active Expired
- 1979-03-29 GB GB7910983A patent/GB2017909B/en not_active Expired
- 1979-03-29 SE SE7902810A patent/SE437731B/sv unknown
- 1979-03-29 AU AU45580/79A patent/AU528893B2/en not_active Ceased
- 1979-03-29 FR FR7907903A patent/FR2421381A1/fr active Granted
- 1979-03-29 CH CH293879A patent/CH642459A5/fr not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| GB2017909B (en) | 1983-01-19 |
| GB2017909A (en) | 1979-10-10 |
| JPS54143200A (en) | 1979-11-08 |
| AU4558079A (en) | 1979-10-04 |
| SE437731B (sv) | 1985-03-11 |
| FR2421381A1 (fr) | 1979-10-26 |
| FR2421381B1 (enExample) | 1984-03-16 |
| JPS5925185B2 (ja) | 1984-06-15 |
| US4170454A (en) | 1979-10-09 |
| DE2912239A1 (de) | 1979-10-04 |
| SE7902810L (sv) | 1979-10-01 |
| DE2912239C2 (de) | 1982-12-30 |
| CA1118346A (en) | 1982-02-16 |
| AU528893B2 (en) | 1983-05-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4244694A (en) | Reactor/separator device for use in automated solid phase immunoassay | |
| CA2172041C (fr) | Procede et dispositif pour la determination d'un analyte dans un echantillon | |
| US3655838A (en) | Method of pelletizing analytical or immunological reagents | |
| JP3257795B2 (ja) | 特異的結合アッセイ用の使用単位の試薬組成物 | |
| CA2167275C (en) | Lyophilized ligand-receptor complexes for assays and sensors | |
| EP0468585B1 (en) | Biologically active reagent, analytical element and methods for use of the reagent | |
| JPH06500853A (ja) | 固相免疫検定のための使い捨て反応容器および免疫反応により検出可能な成分の測定方法 | |
| FR2490826A1 (fr) | Procede pour la mesure de la thyroxine libre ou de la 3,5,3'-triiodothyronine libre dans un echantillon liquide | |
| US4317810A (en) | Waffle-like matrix for immunoassay and preparation thereof | |
| EP0311492B1 (fr) | Trousse et méthode de dosage immunométrique applicables à des cellules entières | |
| CH642459A5 (fr) | Procede de preparation d'un support d'epreuve radioimmunologique en phase solide et son application. | |
| FR2458809A1 (fr) | Procede de determination d'un antigene, d'un anticorps ou d'un complexe antigene-anticorps et necessaire de reactifs de mesure pour ce procede | |
| JP3757171B2 (ja) | 微生物抗原の抽出方法 | |
| US5633140A (en) | Reaction vessel for immunological analysis of aerosols | |
| JP3290660B2 (ja) | 特異的結合検定用の使用単位試薬組成物 | |
| US3562384A (en) | Immunological indicator and test system | |
| CA1118364A (en) | Charcoal coated absorbent device | |
| JPS6342229B2 (enExample) | ||
| AU595899B2 (en) | Method for diagnostic immunoassay by solid phase separation | |
| US5229268A (en) | Method for diagnostic immunoassay by solid phase separation | |
| CH629894A5 (en) | Process for separating the free fractions from the bound fractions in an immunoassay procedure | |
| JPS6224745B2 (enExample) | ||
| JP2763787B2 (ja) | 不均質免疫定量法 | |
| EP0607209A1 (en) | Unit-of-use reagent compositions for specific binding assays | |
| JP2002533725A (ja) | 分析手法で用いられる試料の液体成分および固体成分を提供する方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased | ||
| PL | Patent ceased |